Search results for Cell Free Dna...

Cell-free DNA reveals tumor-linked nucleosomal patterns

In a revolutionary breakthrough poised to redefine cancer diagnostics, researchers have unveiled a cutting-edge technique that meticulously dissects the size of cell-free DNA fragm...

Circulating Tumor DNA (ctDNA)

Why Your Doctor Recommends Circulating Tumor DNA (ctDNA)? Everything You Should Know Abstract Tumor cells continuously shed nucleic acid fragments ... Read more The post Circulatin...

Abstract No. LBA15 Liquid Biopsy Detection of TP53, mGSTP1, and mRASS1Fa from Circulating Tumor DNA Improves the Non-inv...

Alpha fetoprotein (AFP) is used to screen high risk patients for hepatocellular carcinoma (HCC) but has limited sensitivity, demanding the identification of new biomarkers. This st...

New blood test spots four cancers and other diseases by stripping away healthy DNA noise

MethylScan is a new low-cost cell-free DNA methylome test that removes much of the healthy blood DNA background, helping rare disease signals stand out more clearly. In more than 1...

New Blood Test Detects Tumor DNA to Guide Treatment in Advanced Cancer Cases

In a groundbreaking advancement presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026), researchers have unveiled a promising approach to tail...

Low-Cost, Single Sample Blood Test Detects Different Cancers, Liver Disorders, and Other Diseases

Researchers developed a blood test that, in early studies in more than 1,000 people, showed promise as a low-cost method for detecting multiple cancers, various liver conditions, a...

New biomarkers for the detection of fetal death derived from large-scale proteomic analysis of maternal plasma

Normal pregnancy involves modulation of thousands of maternal plasma proteins, and departures from the normal trajectories may be indicative of the development of adverse pregnancy...

DNA-Containing Extracellular Vesicles Boost Antitumor Responses in Mice

Preclinical studies showed that activated T cells secrete DNA-containing extracellular vesicles that enter other immune and tumor cells to stimulate immune responses, boosting T ce...

Integrated Sample Preparation System Standardizes and Streamlines Pre-Analytical Workflows

The Invivoscribe PrepQuant system is assay agnostic, generating highly concentrated genomic DNA and cell free DNA (cfDNA) yields for next-generation sequencing (NGS), qPCR, and dig...

Breast cancer’s next precision medicine revolution may lie in molecular residual disease

New data shows potential for ctDNA to guide treatment decisions for patients with triple-negative breast cancer

New Method Reads a Cell’s Genes Without Killing It

Every few minutes, a living cell does something quietly extraordinary: it sheds tiny membrane bubbles into the fluid around it. These extracellular vesicles carry molecular cargo (...

Su1908 CLINICAL IMPACT OF CYST FLUID NEXT-GENERATION SEQUENCING IN PANCREATIC CYSTS: A SINGLE-CENTER COHORT STUDY

How MRD Testing Is Reshaping Breast Cancer Risk Assessment

New B-59 data shows circulating tumor DNA (ctDNA) and molecular residual disease (MRD) testing can better predict recurrence risk and help guide more personalized care in TNBC.

RNA sequencing identifies blood-based biomarkers for inflammatory breast cancer

RNA sequencing using TGIRT technology reveals blood-based RNA biomarkers that may improve diagnosis and monitoring of inflammatory breast cancer through liquid biopsy...

CareDx to Acquire Naveris for $160M to Expand into HPV-Driven Cancer MRD Monitoring

What You Should Know CareDx has entered into a definitive agreement to acquire Naveris, a precision oncology company specializing in blood-based monitoring for viral-mediated cance...